Remove Government Remove Patients Remove Prescription Remove Specialization
article thumbnail

Pharmacy Innovation Series: the DEA Steps into Telepharmacy Regulation

Nixon Gwilt Law

For the first time, the Drug Enforcement Agency (“DEA”) is becoming directly involved in the telepharmacy space, an industry that the DEA has not previously regulated aside from the loose application of its existing regulations governing online pharmacies. Want to read more about telepharmacy on our blog?

article thumbnail

Kickback Conspiracy: Former Sales Rep Sentenced

Contrarian Sales Techniques

During the trial, prosecutors presented evidence that showed that Tondre was a sales representative for Insys Therapeutics, the company that produced and sold Subsys, a drug that is designed to quickly enter the bloodstream and relieve pain in certain cancer patients. million for the prescriptions that Chun wrote for Subsys.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

article thumbnail

Mainland China’s regulatory evolution brings greater access to novel drugs

Clarivate

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process. In parallel, the CDE also established a special channel to facilitate these approvals.

article thumbnail

Handling Economic Uncertainty: The Focus Pharma Marketers Need

Eversana Intouch

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. .”

article thumbnail

Handling Economic Uncertainy: The Focus Pharma Marketers Need

Eversana Intouch

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. .”

article thumbnail

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Clarify Health

Earlier this year, Clarify Health began offering a new service ( Clarify Trials ) whereby companies could receive a list of the most-ideal sites for studies tied to the characteristics of patients they hope to enroll. Data governance and HIPAA rules around this are very clear—you can’t identify the individual.